Pre‐chemotherapy white blood cell depletion by therapeutic leukocytapheresis in leukemia patients: A single‐institution experience
- 12 December 2019
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 35 (2), 117-124
- https://doi.org/10.1002/jca.21766
Abstract
Background Hyperleukocytosis is commonly seen in acute and chronic leukemias. Therapeutic leukocytapheresis using an automatic cell separator can help to achieve prompt leukoreduction to reduce the rate of thrombotic events and early mortality as well as to prevent tumor lysis syndrome. Aim In this study, we report a single center's experience in managing leukemia patients with therapeutic leukocytapheresis prior to chemotherapy. Materials and Methods Leukocytapheresis procedures were performed in 192 leukemia patients (including acute myeloid leukemia [AML], acute lymphoblastic leukemia [ALL], and chronic myeloid leukemia [CML]) with hyperleukocytosis between January and December 2016. Results Median % reduction of white blood cell (WBC) count was 30.5% and median % removal efficiency was 46.7% for 75 procedures where the waste bag was sampled. WBC removal efficiency strongly depended on diagnosis (and was 71%, 66%, and 39% for ALL, AML, and CML, respectively). Procedures were generally well tolerated with only 9 out of 192 patients having mild adverse effects. Discussion and Conclusion In the absence of specific guidelines for the management of hyperleukocytosis, leukocytapheresis in association with chemotherapy should be considered early in clinical practice.Keywords
This publication has 29 references indexed in Scilit:
- Leukocyte Depletion by Therapeutic Leukocytapheresis in Patients with LeukemiaTransfusion Medicine and Hemotherapy, 2012
- Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemiaJournal of Clinical Apheresis, 2011
- Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemiaJournal of Clinical Pharmacy & Therapeutics, 2009
- Emergency therapeutic leukapheresis in a case of acute myeloid leukemia M5Asian Journal of Transfusion Science, 2008
- Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosisTransfusion, 2007
- Therapeutic Apheresis in Hyperleukocytosis and Hyperviscosity SyndromeSeminars in Thrombosis and Hemostasis, 2007
- Leukocyte count as a predictor of death during remission induction in acute myeloid leukemiaLeukemia & Lymphoma, 2006
- Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Blood, 2002
- Leukapheresis Reduces Early Mortality in Patients with Acute Myeloid Leukemia with High White Cell Counts But Does Not Improve Long Term SurvivalLeukemia & Lymphoma, 2001
- Adhesion efficiency, platelet density and sizeBritish Journal of Haematology, 1992